This toolkit is a collection of tools, job aids, and evidence-based resources related to screening, testing, staging, and treating syphilis. It is intended for Title X staff but includes resources that can be useful for any sexual and reproductive health provider.
This client information sheet can be shared and disseminated to clients being treated with Penicillin G Benzathine.
Title X agencies should have all patient-facing materials, such as the handout above, reviewed and adapted by their Informational & Educational (I&E) Advisory Committee. Learn more about I&E Materials Review.
Long-acting penicillin G benzathine (Bicillin L-A®) is the preferred antibiotic treatment for patients in all stages of syphilis. This job aid focuses on treatment with an emphasis on dosage by stage, administration of the injection, side effects, and other considerations for using penicillin G benzathine.
This algorithm will support providers by establishing a workflow for syphilis point-of-care testing.
This job aid will support providers by offering a set of suggested scripts for discussing testing, results, and treatment with clients.
This job aid offers providers a quick reference guide for scripts to normalize and opt out of syphilis screening.
This job aid offers providers a quick reference guide to screening and staging syphilis.
This job aid offers providers a quick reference guide to syphilis treatment.
This algorithm will support providers in staging and treatment for early primary, secondary, and early latent syphilis.
This algorithm assists providers in treating clients considered to have late latent syphilis (>1 year duration) or syphilis of unknown duration.
This patient information resource can be offered to clients who are interested in or who have been prescribed Doxy PEP as a post-exposure prophylaxis to prevent the acquisition of gonorrhea, chlamydia, and syphilis.
Title X agencies should have all patient-facing materials, such as the handout above, reviewed and adapted by their Informational & Educational (I&E) Advisory Committee. Learn more about I&E Materials Review.
This job aid supports providers in counseling, prescribing, and monitoring Doxy PEP as a post-exposure prophylaxis to prevent the acquisition of gonorrhea, chlamydia, and syphilis.
This algorithm assists providers in screening for syphilis starting with an initial nontreponemal test (e.g., Venereal Disease Research Laboratory [VDRL] or rapid plasma reagin [RPR] test) then confirming positive results with a reflex treponemal antibody detection test (e.g., fluorescent treponemal antibody absorbed [FTA-ABS] test, chemoluminescence immunoassays [CIA], enzyme immunoassays [EIA], or T pallidum particle agglutination [TP-PA] test).
This algorithm assists providers in screening for syphilis, starting with an initial automated treponemal test (e.g., fluorescent treponemal antibody absorbed [FTA-ABS] test, chemoluminescence immunoassays [CIA], enzyme immunoassays [EIA], or T pallidum particle agglutination [TP-PA] test) and then confirming positive results with a reflex nontreponemal test (e.g., Venereal Disease Research Laboratory [VDRL] or rapid plasma reagin [RPR] test).
In response to the rising rates of congenital syphilis infections, the CTC-SRH speaks with Dr. Kate Miele from the Centers for Disease Control and Prevention to review conventional testing and treatment protocols for syphilis.
In response to the rising rates of congenital syphilis infections, the CTC-SRH's own Associate Director, Tammy Bennett, will be discussing point-of-care testing and same-day treatment for syphilis infections and how Title X sites can implement these services in their own clinics.
Listen to this podcast for free on our website using the players above, downloading it to your computer, or stream on your phone by searching for The Family Planning Files on your favorite podcast app.
The NCTCFP speaks with Dr. Ina Park, from UCSF School of Medicine, about current rates of syphilis in the US, including congenital and neurosyphilis. The first of a three-part series. This podcast series is funded by an award from the US DHHS Office of Population Affairs. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of HHS, OASH, or OPA. A transcript of the podcast is available below.
The NCTCFP speaks with Dr. Ina Park, from UCSF School of Medicine, about the signs and symptoms of syphilis in all stages of infection, and how they can aid clinicians in staging and diagnosis. The second of a three-part series. This podcast series is funded by an award from the US DHHS Office of Population Affairs. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of HHS, OASH, or OPA. A transcript of the podcast is available below.
The NCTCFP speaks with Dr. Ina Park, from UCSF School of Medicine, about the CDC recommended testing and treatment guidelines for syphilis infections in all stages. The third of a three-part series. This podcast series is funded by an award from the US DHHS Office of Population Affairs. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of HHS, OASH, or OPA. A transcript of the podcast is available below.
